| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.597 | 0.054 | 0.641 | Antiinflammatory | 0.641 0.043 CID_154700094 | CID_154700094 | |
| 0.507 | 0.024 | 0.507 | GABA C receptor rho-3 antagonist | |||
| 0.486 | 0.006 | 0.486 | TRKC antagonist | 0.149 0.102 CID_154700102 | ||
| 0.494 | 0.024 | 0.494 | Immunomodulator | 0.215 0.147 CID_154700102 0.364 0.055 CID_154700094 | ||
| 0.439 | 0.046 | 0.439 | Toll-Like receptor agonist | 0.378 0.069 CID_154700102 | ||
| 0.373 | 0.005 | 0.373 | TRKB antagonist | 0.128 0.064 CID_154700102 | ||
| 0.413 | 0.055 | 0.413 | Toll-Like receptor 7 agonist | 0.365 0.075 CID_154700102 | ||
| 0.316 | 0.006 | 0.316 | CDK2/cyclin A inhibitor | 0.091 0.066 CID_154700094 | ||
| 0.297 | 0.007 | 0.297 | Toll-Like receptor antagonist | |||
| 0.298 | 0.013 | 0.298 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.34 | 0.104 | 0.34 | Histamine release inhibitor | 0.33 0.109 CID_154700094 | ||
| 0.241 | 0.005 | 0.241 | Nitric-oxide synthase inhibitor | |||
| 0.216 | 0.015 | 0.216 | Nav1.6 sodium channel blocker | 0.128 0.084 CID_154700102 | ||
| 0.243 | 0.049 | 0.243 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.194 | 0.01 | 0.194 | Adenosine A2a receptor antagonist | 0.059 0.045 CID_154700102 | ||
| 0.287 | 0.105 | 0.287 | Calcium channel activator | |||
| 0.188 | 0.012 | 0.188 | Adenosine A2 receptor antagonist | |||
| 0.208 | 0.035 | 0.208 | Cyclin-dependent kinase inhibitor | |||
| 0.201 | 0.035 | 0.201 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.198 | 0.043 | 0.198 | RET inhibitor | |||
| 0.228 | 0.075 | 0.429 | Cyclic AMP phosphodiesterase inhibitor | 0.429 0.013 CID_154700094 | CID_154700094 | |
| 0.189 | 0.038 | 0.189 | Phosphodiesterase inhibitor | |||
| 0.182 | 0.04 | 0.182 | GABA C receptor rho-2 antagonist | |||
| 0.154 | 0.014 | 0.154 | MAP-kinase-activated kinase inhibitor | |||
| 0.278 | 0.145 | 0.278 | 15-Lipoxygenase inhibitor | |||
| 0.146 | 0.015 | 0.146 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.143 | 0.012 | 0.143 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.158 | 0.027 | 0.158 | CDK/cyclin complex inhibitor | |||
| 0.182 | 0.052 | 0.182 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.197 | 0.069 | 0.197 | CDC-like kinase 4 inhibitor | |||
| 0.159 | 0.034 | 0.159 | Ferrochelatase inhibitor | |||
| 0.177 | 0.067 | 0.177 | Src kinase inhibitor | |||
| 0.182 | 0.072 | 0.182 | LIM domain kinase 1 inhibitor | |||
| 0.161 | 0.058 | 0.161 | Tyrosine-protein kinase receptor antagonist | |||
| 0.133 | 0.03 | 0.133 | GABA C receptor rho-1 antagonist | |||
| 0.151 | 0.049 | 0.151 | TRKA antagonist | |||
| 0.131 | 0.03 | 0.131 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.123 | 0.024 | 0.123 | Inducible nitric-oxide synthase inhibitor | |||
| 0.144 | 0.045 | 0.144 | Protein kinase (CK2) alpha inhibitor | |||
| 0.12 | 0.023 | 0.12 | CDK2/cyclin E2 inhibitor | |||
| 0.185 | 0.088 | 0.185 | Clk dual-specificity kinase inhibitor | |||
| 0.155 | 0.062 | 0.155 | Lck kinase inhibitor | |||
| 0.1 | 0.008 | 0.1 | Cyclin A1 inhibitor | |||
| 0.111 | 0.023 | 0.111 | mTOR complex 2 inhibitor | |||
| 0.128 | 0.045 | 0.128 | GABA C receptor antagonist | |||
| 0.092 | 0.012 | 0.092 | Potassium channel (Ca-activated) blocker | |||
| 0.18 | 0.102 | 0.18 | EphB2 antagonist | |||
| 0.089 | 0.013 | 0.089 | Toll-Like receptor 8 antagonist | |||
| 0.182 | 0.11 | 0.182 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.083 | 0.013 | 0.083 | Histamine agonist | |||
| 0.104 | 0.033 | 0.104 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.138 | 0.069 | 0.138 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.082 | 0.013 | 0.082 | Phosphodiesterase X inhibitor | |||
| 0.082 | 0.013 | 0.082 | Phosphodiesterase 10A inhibitor | |||
| 0.141 | 0.074 | 0.141 | Protein kinase (CK1) inhibitor | |||
| 0.269 | 0.202 | 0.269 | 5 Hydroxytryptamine release inhibitor | |||
| 0.096 | 0.03 | 0.096 | Check point kinase 1 inhibitor | |||
| 0.073 | 0.006 | 0.073 | Cytokine production stimulant | |||
| 0.089 | 0.024 | 0.089 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.111 | 0.048 | 0.111 | Folate antagonist | |||
| 0.072 | 0.01 | 0.072 | Guanylate cyclase stimulant | |||
| 0.063 | 0.005 | 0.063 | Angiotensin AT1 receptor antagonist | 0.061 0.005 CID_154700102 | ||
| 0.08 | 0.025 | 0.08 | Potassium channel Kv1.5 blocker | |||
| 0.078 | 0.022 | 0.078 | Neuropeptide Y5 antagonist | |||
| 0.059 | 0.005 | 0.059 | Corticotropin releasing factor 1 receptor antagonist | 0.023 0.015 CID_154700102 | ||
| 0.072 | 0.018 | 0.072 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.084 | 0.031 | 0.084 | Cyclin A2 inhibitor | |||
| 0.056 | 0.005 | 0.056 | Angiotensin II receptor antagonist | 0.051 0.006 CID_154700102 | ||
| 0.082 | 0.031 | 0.082 | Phosphodiesterase VIII inhibitor | |||
| 0.215 | 0.165 | 0.287 | Interleukin 2 agonist | 0.287 0.083 CID_154700094 | CID_154700094 | |
| 0.146 | 0.096 | 0.146 | CDC-like kinase 2 inhibitor | |||
| 0.068 | 0.019 | 0.068 | Adenosine A2b receptor antagonist | |||
| 0.063 | 0.016 | 0.063 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.057 | 0.011 | 0.057 | Histamine H1 receptor agonist | |||
| 0.077 | 0.033 | 0.077 | Cyclin A inhibitor | |||
| 0.098 | 0.055 | 0.098 | Toll-Like receptor 3 antagonist | |||
| 0.118 | 0.075 | 0.118 | Protein kinase (CK1) delta inhibitor | |||
| 0.073 | 0.032 | 0.073 | Adenosine A1 receptor antagonist | |||
| 0.061 | 0.02 | 0.061 | Adenosine deaminase inhibitor | |||
| 0.051 | 0.01 | 0.051 | Histamine H3 receptor agonist | |||
| 0.054 | 0.013 | 0.054 | Nicotinic acid receptor agonist | |||
| 0.072 | 0.033 | 0.072 | Interferon inducer | |||
| 0.084 | 0.046 | 0.084 | Interferon agonist | |||
| 0.043 | 0.005 | 0.043 | Purinergic P2Y15 antagonist | |||
| 0.209 | 0.174 | 0.209 | Vasodilator, coronary | |||
| 0.048 | 0.015 | 0.048 | MAP3K5 inhibitor | |||
| 0.089 | 0.056 | 0.089 | Interleukin 5 antagonist | |||
| 0.104 | 0.071 | 0.104 | 5 Hydroxytryptamine 3A agonist | |||
| 0.1 | 0.068 | 0.1 | Adenylate kinase inhibitor | |||
| 0.089 | 0.06 | 0.089 | Phosphodiesterase I inhibitor | |||
| 0.05 | 0.021 | 0.05 | Histamine H2 receptor agonist | |||
| 0.065 | 0.037 | 0.065 | Phosphodiesterase 1C inhibitor | |||
| 0.057 | 0.029 | 0.086 | Factor IXa inhibitor | 0.086 0.014 CID_154700094 | CID_154700094 | |
| 0.095 | 0.069 | 0.095 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.029 | 0.003 | 0.029 | Corticotropin releasing factor antagonist | |||
| 0.029 | 0.005 | 0.029 | Toll-Like receptor 8 agonist | |||
| 0.038 | 0.014 | 0.038 | Transforming growth factor beta 2 antagonist | |||
| 0.061 | 0.04 | 0.061 | Carbonic anhydrase stimulant | 0.059 0.041 CID_154700102 | ||
| 0.083 | 0.062 | 0.083 | Myeloperoxidase inhibitor | |||
| 0.025 | 0.005 | 0.025 | Nicotinic acid receptor 1 antagonist | |||
| 0.069 | 0.05 | 0.069 | Transforming growth factor antagonist | |||
| 0.071 | 0.053 | 0.071 | MAP3K7 inhibitor | |||
| 0.027 | 0.01 | 0.027 | Bombesin agonist | |||
| 0.117 | 0.1 | 0.117 | Activin receptor-like kinase 2 inhibitor | |||
| 0.101 | 0.084 | 0.101 | Activin receptor-like kinase 4 inhibitor | |||
| 0.025 | 0.009 | 0.025 | Guanylate cyclase 1 stimulant | |||
| 0.13 | 0.114 | 0.13 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.194 | 0.177 | 0.327 | Angiogenesis inhibitor | 0.327 0.08 CID_154700102 0.274 0.107 CID_154700094 | CID_154700102 | |
| 0.025 | 0.008 | 0.025 | Histamine H4 receptor agonist | |||
| 0.045 | 0.029 | 0.045 | Geranyltranstransferase inhibitor | |||
| 0.169 | 0.154 | 0.169 | Nitric-oxide synthase stimulant | |||
| 0.092 | 0.077 | 0.092 | GABA C receptor agonist | |||
| 0.089 | 0.074 | 0.089 | MAP kinase 8 inhibitor | |||
| 0.022 | 0.007 | 0.022 | Adenosine A2a receptor agonist | 0.017 0.009 CID_154700094 | ||
| 0.023 | 0.009 | 0.023 | Bombesin 3 receptor agonist | |||
| 0.066 | 0.051 | 0.066 | Glutamate (mGluR7) antagonist | |||
| 0.08 | 0.066 | 0.08 | Transforming growth factor beta 3 antagonist | |||
| 0.029 | 0.015 | 0.029 | Glucosylceramidase stimulant | |||
| 0.043 | 0.029 | 0.043 | GABA B receptor antagonist | |||
| 0.09 | 0.076 | 0.09 | MAP kinase kinase kinase inhibitor | |||
| 0.042 | 0.03 | 0.042 | Oxytocin agonist | |||
| 0.058 | 0.046 | 0.058 | Phosphodiesterase 1A inhibitor | |||
| 0.087 | 0.076 | 0.087 | Protein kinase (CK2) inhibitor | |||
| 0.019 | 0.009 | 0.024 | Adenosine A2 receptor agonist | 0.024 0.006 CID_154700094 | CID_154700094 | |
| 0.147 | 0.138 | 0.147 | Potassium channel blocker | |||
| 0.097 | 0.087 | 0.097 | CDC-like kinase 3 inhibitor | |||
| 0.022 | 0.014 | 0.022 | Angiotensin AT1A receptor antagonist | |||
| 0.02 | 0.012 | 0.02 | Integrin alphaVbeta1 antagonist | |||
| 0.03 | 0.023 | 0.03 | Potassium channel small-conductance Ca-activated activator | |||
| 0.096 | 0.089 | 0.096 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.096 | 0.089 | 0.096 | Abl kinase inhibitor | |||
| 0.09 | 0.084 | 0.09 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.031 | 0.026 | 0.031 | ATR kinase inhibitor | |||
| 0.025 | 0.021 | 0.025 | Nicotinic acid receptor 2 antagonist | |||
| 0.014 | 0.01 | 0.014 | Integrin beta6 antagonist | |||
| 0.048 | 0.045 | 0.056 | Carbonic anhydrase II stimulant | 0.056 0.029 CID_154700102 | CID_154700102 | |
| 0.105 | 0.104 | 0.105 | Toll-Like receptor 9 antagonist | |||
| 0.165 | 0.164 | 0.165 | RNA-directed DNA polymerase inhibitor | |||
| 0.045 | 0.064 | 0.086 | Glucosylceramidase inhibitor | 0.086 0.013 CID_154700094 | CID_154700094 | |
| 0.025 | 0.084 | 0.052 | Mannosidase inhibitor | 0.052 0.023 CID_154700094 | CID_154700094 | |
| 0.023 | 0.084 | 0.045 | Antimetabolite | 0.045 0.035 CID_154700094 | CID_154700094 | |
| 0.067 | 0.14 | 0.134 | DNA polymerase I inhibitor | 0.134 0.059 CID_154700094 | CID_154700094 | |
| 0.094 | 0.177 | 0.197 | Insulin secretagoues | 0.197 0.037 CID_154700094 | CID_154700094 | |
| 0.028 | 0.119 | 0.055 | Alpha-mannosidase inhibitor | 0.055 0.035 CID_154700094 | CID_154700094 | |
| 0.169 | 0.27 | 0.454 | Antibacterial | 0.234 0.192 CID_154700102 0.454 0.055 CID_154700094 | CID_154700094 | |
| 0.135 | 0.237 | 0.338 | DNA synthesis inhibitor | 0.338 0.033 CID_154700094 | CID_154700094 | |
| 0.015 | 0.127 | 0.081 | Carbonic anhydrase VB inhibitor | 0.081 0.022 CID_154700102 | CID_154700102 | |
| 0.018 | 0.216 | 0.061 | Carbonic anhydrase V inhibitor | 0.061 0.052 CID_154700102 | CID_154700102 | |
| 0.072 | 0.284 | 0.335 | Immunostimulant | 0.335 0.069 CID_154700094 | CID_154700094 | |
| 0.005 | 0.241 | 0.022 | Adenosine A1 receptor agonist | 0.022 0.019 CID_154700094 | CID_154700094 | |
| 0.137 | 0.385 | 0.542 | Cyclophilin D inhibitor | 0.282 0.179 CID_154700102 0.542 0.039 CID_154700094 | CID_154700094 | |
| 0.095 | 0.405 | 0.279 | Sodium/bile acid cotransporter inhibitor | 0.279 0.099 CID_154700102 | CID_154700102 | |
| 0.021 | 0.372 | 0.118 | Alkylator | 0.118 0.07 CID_154700094 | CID_154700094 | |
| 0.014 | 0.388 | 0.036 | Antibiotic Aminoglycoside-like | 0.036 0.026 CID_154700094 | CID_154700094 | |
| 0.063 | 0.45 | 0.209 | Hypoglycemic | 0.209 0.104 CID_154700094 | CID_154700094 | |
| 0.057 | 0.451 | 0.4 | Immunosuppressant | 0.4 0.063 CID_154700094 | CID_154700094 | |
| 0.073 | 0.48 | 0.174 | Catenin beta inhibitor | 0.174 0.06 CID_154700094 | CID_154700094 | |
| 0.037 | 0.482 | 0.147 | Platelet adhesion inhibitor | 0.147 0.11 CID_154700094 | CID_154700094 | |
| 0.038 | 0.484 | 0.196 | Antioxidant | 0.196 0.116 CID_154700094 | CID_154700094 | |
| 0.085 | 0.549 | 0.246 | Peptidyltransferase inhibitor | 0.246 0.054 CID_154700094 | CID_154700094 | |
| 0.025 | 0.499 | 0.278 | Angiogenesis stimulant | 0.278 0.058 CID_154700094 | CID_154700094 | |
| 0.016 | 0.524 | 0.086 | Aminoacyl-tRNA synthetase inhibitor | 0.086 0.066 CID_154700102 | CID_154700102 | |
| 0.016 | 0.591 | 0.119 | Anticoagulant | 0.119 0.114 CID_154700102 | CID_154700102 | |
| 0.005 | 0.586 | 0.133 | Selectin antagonist | 0.133 0.02 CID_154700094 | CID_154700094 | |
| 0.011 | 0.634 | 0.149 | Lipid peroxidase inhibitor | 0.149 0.069 CID_154700094 | CID_154700094 | |
| 0.003 | 0.709 | 0.087 | Antineoplastic antibiotic | 0.087 0.053 CID_154700094 | CID_154700094 | |
| 0.021 | 0.819 | 0.145 | Hepatoprotectant | 0.145 0.115 CID_154700094 | CID_154700094 | |
| 0.007 | 0.823 | 0.225 | Dual specificity phosphatase 3 inhibitor | 0.225 0.049 CID_154700102 | CID_154700102 | |
| 0.002 | 0.82 | 0.138 | Estrone sulfatase inhibitor | 0.138 0.004 CID_154700102 | CID_154700102 | |
| 0.004 | 0.836 | 0.125 | Protein-tyrosine phosphatase 1B inhibitor | 0.125 0.059 CID_154700102 | CID_154700102 | |
| 0.014 | 0.85 | 0.322 | Apoptosis agonist | 0.322 0.157 CID_154700094 | CID_154700094 | |
| 0.007 | 0.866 | 0.179 | Dual specificity phosphatase inhibitor | 0.179 0.068 CID_154700102 | CID_154700102 | |
| 0.004 | 0.887 | 0.717 | Protein-tyrosine phosphatase inhibitor | 0.717 0.003 CID_154700102 | CID_154700102 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |